Jifang Weng

Title: Innovations by Jifang Weng in Heterocyclic Compounds

Introduction

Jifang Weng is a notable inventor based in Shanghai, China. He has made significant contributions to the field of chemistry, particularly in the development of novel heterocyclic compounds. With a total of three patents to his name, Weng's work focuses on innovative methods for preparing and utilizing these compounds in medical applications.

Latest Patents

Weng's latest patents include groundbreaking research on heterocyclic compounds and their preparation methods. One of his patents details novel heterocyclic compounds, including those represented by Formula I. This patent also outlines methods for preparing these compounds and their applications in inhibiting TGF-beta mediated signaling and treating cancer. Another patent focuses on compounds with Formula (I) or Formula (II), or their pharmaceutically acceptable salts. This work emphasizes methods for preparing these compounds and their use in inhibiting KRAS G12C in cells, as well as treating various cancers such as pancreatic, endometrial, colorectal, and non-small cell lung cancer.

Career Highlights

Jifang Weng is currently associated with Inventisbio Co., Ltd., where he continues to advance his research in the field of heterocyclic compounds. His innovative approach and dedication to scientific discovery have positioned him as a key figure in his area of expertise.

Collaborations

Throughout his career, W